Overview

Fecal Microbiota Transplantation (FMT) as a Prophylaxis of Necrotizing Enterocolitis (NEC) - Clinical Study

Status:
NOT_YET_RECRUITING
Trial end date:
2025-01-31
Target enrollment:
Participant gender:
Summary
The aim of the study is to assess the safety of fecal microbiota transplantation (FMT) as a preventive method for the development of Necrotizing enterocolitis (NEC) in a group of premature infants. This is the first stage of a clinical trial testing the effectiveness of FMT in NEC, the aim of which is to examine the safety profile and analyze all side effects.
Phase:
NA
Details
Lead Sponsor:
Medical University of Warsaw
Treatments:
Fecal Microbiota Transplantation